Health Catalyst HCAT
$ 7.66
4.08%
Annual report 2023
added 02-22-2024
Health Catalyst Balance Sheet 2011-2024 | HCAT
Annual Balance Sheet Health Catalyst
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
125 M | 114 M | -8.86 M | 79.7 M | 240 M | -1.52 M | -10.4 M | - | - | - | - | - | - |
Long Term Debt |
228 M | 227 M | 181 M | 169 M | 48.2 M | 18.8 M | 9.62 M | - | - | - | - | - | - |
Long Term Debt Current |
3.36 M | 3.43 M | 3.42 M | 2.62 M | 2.81 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 53.5 M | 444 M | 339 M | - | - | - | - | - | - |
Total Current Liabilities |
89 M | 82.5 M | 93.1 M | 88 M | 48.2 M | - | - | - | - | - | - | - | - |
Total Liabilities |
335 M | 327 M | 310 M | 302 M | 102 M | 486 M | 370 M | - | - | - | - | - | - |
Deferred Revenue |
55.8 M | 55 M | 56.6 M | 47.1 M | 30.7 M | 24.8 M | 10.7 M | - | - | - | - | - | - |
Retained Earnings |
-1.12 B | -999 M | -879 M | - | -611 M | -375 M | -259 M | - | - | - | - | - | - |
Total Assets |
702 M | 752 M | 832 M | 578 M | 302 M | 111 M | 110 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
106 M | 116 M | 193 M | 92 M | 18 M | 28.4 M | 23 M | - | - | - | - | - | - |
Book Value |
367 M | 425 M | 522 M | 276 M | 201 M | -375 M | -259 M | - | - | - | - | - | - |
Total Shareholders Equity |
367 M | 425 M | 522 M | 276 M | 201 M | -375 M | -259 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Health Catalyst
2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
228 M | 227 M | - | - | 225 M | 181 M | - | - | - | 169 M | 169 M | 169 M | 169 M | 48.2 M | 48.2 M | 48.2 M | 48.2 M | 18.8 M | 18.8 M | 18.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
331 M | 327 M | - | - | 344 M | 310 M | 296 M | 287 M | 302 M | 302 M | 302 M | 302 M | 302 M | 102 M | 102 M | 102 M | 102 M | 75.9 M | 75.9 M | 75.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
53.1 M | 55 M | - | - | 61.8 M | 56.6 M | 55.3 M | 55.6 M | 51.6 M | 47.1 M | 47.1 M | 47.1 M | 47.1 M | 30.7 M | 30.7 M | 30.7 M | 30.7 M | 24.8 M | 24.8 M | 24.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.09 B | -999 M | - | - | -884 M | -879 M | -830 M | -790 M | -754 M | -726 M | -726 M | -726 M | -726 M | -611 M | -611 M | -611 M | -611 M | -375 M | -375 M | -375 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
713 M | 752 M | - | - | 825 M | 832 M | 846 M | 563 M | 571 M | 578 M | 578 M | 578 M | 578 M | 302 M | 302 M | 302 M | 302 M | 111 M | 111 M | 111 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
95 M | 116 M | 124 M | - | 198 M | 193 M | 276 M | 205 M | 133 M | 92 M | 92 M | 92 M | 92 M | 18 M | 18 M | 18 M | 18 M | 28.4 M | 28.4 M | 28.4 M | - | 23 M | - | - | - | 12.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
382 M | 425 M | - | - | 481 M | 522 M | 549 M | 276 M | 269 M | 276 M | 276 M | 276 M | 276 M | 201 M | 201 M | 201 M | 201 M | 35.1 M | 35.1 M | 35.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
382 M | 425 M | 440 M | - | 481 M | 522 M | 549 M | 276 M | 269 M | 276 M | 276 M | 276 M | 276 M | 201 M | 201 M | 201 M | 201 M | -375 M | -375 M | -375 M | -260 M | -259 M | - | - | - | -206 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency